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 Division of Reproductive Science Research  
 
The Reproductive Science Research 
Division in the Department of Obstetrics 
and Gynecology was established in 
2009 and consists of five full time 
research faculty members and 11 
faculty members with joint appointment 
with other divisions in the department.  
 
Members in the Research Division 
conducted diverse areas of basic 
reproductive research:  
 
Dr. Borowski: Maternal cholesterol and 
outcomes of pregnancy and 
genetic variation in IUGR.  
Dr. Bradley: Female urinary 
incontinence and other pelvic 
floor disorders.  
Dr. Dai: Novel prognostic indicator 
integrating genome sequencing 
data and tumor evolution history 
for prediction of endometrial 
cancer outcome.  
Dr.  Devor: The role of microRNAs and 
other non-coding RNAs, 
specifically H19 and miR-675, in 
differentiating among endometrial 
cancers. Developing miR-675 as 
a potential biomarker of more 
aggressive tumors.  
Dr. Goodheart: The role of Lef-1 in 
endometrial gland formation and 
cancer. Angiogenic markers in 
ovarian cancer.  
 
 
Dr. Hunter: Non-dietary treatment of 
mPKU; the vaccine development 
against GBS; the mechanism and 
potential treatment of pre-
eclampsia.  
Dr. Korovkina: Large conductance Ca2+ 
and voltage activated K+ 
channels regulate proliferation in 
human breast carcinoma cells.  
Dr. Leslie: The molecular biology of 
estrogen and progesterone 
receptors in the treatment of 
endometrial cancer, and identify 
molecular targets linked to 
response in clinical trials.  
Dr. Meng: New prognosis biomarkers 
and potential therapeutic targets 
in gynecology; restore 
progesterone receptor gene 
expression to improve the 
efficacy of hormone therapy in 
endometrial cancer; synthetic 
lethal studies in gynecology.  
Dr. D. Santillan: Development of a GBS 
vaccine, Understanding the role 
of Placental Hematopoietic Stem 
Cells, Developing a Maternal-
Fetal Tissue Bank, Immune 
Modulators of Preeclampsia.  
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Dr. M. Santillan: Investigating the role of 
immunology in the pathogenesis 
of preeclampsia, determining 
molecular mechanisms of 
vascular function changes in 
mice and humans throughout 
pregnancy, development of a 
prospectively collected Maternal 
Fetal Tissue Bank and Clinical 
Database.  
Dr. Sparks: Gamete biology; in vitro 
fertilization; embryo culture; and 
gamete/embryo cryopreservation  
Dr. Stegmann: Fertility preservation in 
cancer patients.  
Dr. Stockdale: Vulvar and lower genital 
tract disease. 
Dr. Williamson: Development of human 
ES and iPS cells with genetic 
mutations related to muscular 
dystrophies 
Dr. Yang: Development of mouse iPS 
cells; the mechanism and 
potential treatment of salt-
sensitive hypertension; IGF-1 
signaling regulation by Nedd4 
during normal and malignant 
growth.  
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